Thought Leadership
A collection of our longer-form, in-depth, perspectives from across the William Blair enterprise.
Investment Banking
William Blair Private Capital Advisory: 2024 Secondary Market Report
The secondary market showed resilience in 2023, with overall volume increasing by 5% year-over-year despite macroeconomic challenges, and market insiders are bullish about prospects for 2024.
Read more
Investment Banking
Aviation Services Industry Update
A strong fourth quarter offered encouraging signs for business jet and general aviation’s continued recovery.
Read more
Equity Research
The Economics Behind the GLP-1 Phenomenon
Equity research analyst Ryan Daniels examines the growing impact of GLP-1 drugs on healthcare spending and care delivery, along with the needs for health providers, employers, and consumers to effectively manage the emerging wave of GLP-1 drugs.
Read more
Equity Research
How Material Science Companies are Changing the Industrials Landscape
Material science tech companies are positively disrupting traditional products by melding innovation with sustainability. Equity analyst Ryan Merkel, CFA, explores why two markets—construction and packaging—are ripe for change.
Read more
Equity Research
The Battle of Silicon vs. Lithium Metal
The battery industry has been in search of a revolution. While new architectures like Lithium-metal anodes and solid-state designs have received the lion’s share of development, funding, and investor attention, Jed Dorsheimer outlines his contrary thesis of why high-content silicon may deliver the evolution that the battery industry actually needs.
Read more
Investment Management
U.S. Onshoring and Its Impact on U.S.-Centric Companies
As onshoring continues to reshape the global trade landscape, it is crucial for investors to understand its impact, as Rob Lanphier, partner, and Jim Jones, CFA, partner, explain. This article is featured on William Blair Investment Management's Active Never Rests blog.
Read more
Equity Research
Cell Therapy and Autoimmune Disorders: Expanding CAR-Ts’ Utility Beyond Oncology
Equity research analysts Sami Corwin and Matt Phipps provide an overview of the known biological underpinnings of autoimmunity and the rationale for using chimeric antigen receptor T cells (CAR-Ts) to potentially treat millions who suffer from autoimmune diseases.
Read moreInvestment Banking
Aviation Services Industry Update
Encouraging business jet activity in recent months and positive Q3 trendlines for U.S. general aviation point to global aviation’s continued recovery.
Read more
Investment Banking
Increasingly Sophisticated Threats and Evolving Workplaces Prompt Sweeping Upgrades to U.S. Digital Infrastructure
A whole-of-government effort is underway to modernize the federal IT infrastructure and to establish its security and upkeep as indispensable to national security.
Read more
Investment Banking
Trick or Treat? Will the 2023 Leveraged Loan Market End on a Sweet Note or Leave Investors Haunted?
The U.S. institutional leveraged loan market showed signs of life in Q3, surging to the strongest quarter in 18 months as lender aggressiveness awoke from the grave.
Read more